Skip to main content
Erschienen in: Endocrine 3/2012

01.06.2012 | Original Article

Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system

verfasst von: C. A. Carrasco, M. García, M. Goycoolea, J. Cerda, J. Bertherat, O. Padilla, D. Meza, N. Wohllk, T. Quiroga

Erschienen in: Endocrine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this article is to evaluate the variability and reproducibility of late night salivary cortisol (LNSC) using electrochemiluminescence immunoassay (ECLIA) and compare the accuracy of one or two samples in diagnosis of Cushing’s syndrome (CS). We prospectively included 64 healthy volunteers (HV), 35 patients with clinically suspected CS (S), and 26 patients with confirmed CS. Nine patients in the CS group had 24-h urinary free cortisol (UFC) less than two times the upper limit of normal (mild CS). UFC and two consecutive LNSC (LNSC1, LNSC2) were collected at home. All patients in the S group had normal UFC and low-dose dexamethasone suppression test. No differences were found between the HV and S groups in UFC, LNSC1, and LNSC2. Intra-individual variability between the two samples of LNSC was 22% in HV (1.6−91%), 32% in the S group (1.6−144%), and 51% (1.6−156%) in the CS group. Variability was higher in CS patients than those in the HV (P < 0.001) and S groups (P = 0.05). The AUC of LNSC1 was 0.945 (IC 95% 0.880–1.004); when considering the highest LNSC, the AUC was 0.980 (IC 95% 0.954–1.007) (P < 0.01). We found 23% of discordant LNSC in the S group and 11% in the CS group. Three patients with CS had only one elevated LNSC, all of them with mild CS. Our results suggest that LNSC is variable, and reproducibility is affected in both CS and S patients. We found significant improvements in the diagnostic accuracy of the LNSC measurement by obtaining two samples.
Literatur
1.
Zurück zum Zitat L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)PubMedCrossRef L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)PubMedCrossRef
2.
Zurück zum Zitat M. Groschl, R. Wagner, M. Rauh, H.G. Dorr, Stability of salivary steroids: the influences of storage, food and dental care. Steroids 66, 737–741 (2001)PubMedCrossRef M. Groschl, R. Wagner, M. Rauh, H.G. Dorr, Stability of salivary steroids: the influences of storage, food and dental care. Steroids 66, 737–741 (2001)PubMedCrossRef
3.
Zurück zum Zitat C.A. Carrasco, J. Coste, L. Guignat, L. Groussin, M.A. Dugue, S. Gaillard, X. Bertagna, J. Bertherat, Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J. Clin. Endocrinol. Metab. 93, 4728–4734 (2008)PubMedCrossRef C.A. Carrasco, J. Coste, L. Guignat, L. Groussin, M.A. Dugue, S. Gaillard, X. Bertagna, J. Bertherat, Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J. Clin. Endocrinol. Metab. 93, 4728–4734 (2008)PubMedCrossRef
4.
Zurück zum Zitat M.L. Nunes, S. Vattaut, J.B. Corcuff, A. Rault, H. Loiseau, B. Gatta, N. Valli, L. Letenneur, A. Tabarin, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456–462 (2009)PubMedCrossRef M.L. Nunes, S. Vattaut, J.B. Corcuff, A. Rault, H. Loiseau, B. Gatta, N. Valli, L. Letenneur, A. Tabarin, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456–462 (2009)PubMedCrossRef
5.
Zurück zum Zitat J.W. Findling, H. Raff, Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol. Metab. Clin. North Am. 30, 729–747 (2001)PubMedCrossRef J.W. Findling, H. Raff, Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol. Metab. Clin. North Am. 30, 729–747 (2001)PubMedCrossRef
6.
Zurück zum Zitat A. Viardot, P. Huber, J.J. Puder, H. Zulewski, U. Keller, B. Muller, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730–5736 (2005)PubMedCrossRef A. Viardot, P. Huber, J.J. Puder, H. Zulewski, U. Keller, B. Muller, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730–5736 (2005)PubMedCrossRef
7.
Zurück zum Zitat E.M. Cardoso, A.L. Arregger, O.R. Tumilasci, L.N. Contreras, Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin. Endocrinol (Oxf). 70, 516–521 (2009)CrossRef E.M. Cardoso, A.L. Arregger, O.R. Tumilasci, L.N. Contreras, Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin. Endocrinol (Oxf). 70, 516–521 (2009)CrossRef
8.
Zurück zum Zitat R.K. Zerikly, L. Amiri, C. Faiman, M. Gupta, R.J. Singh, B. Nutter, L. Kennedy, B. Hatipoglu, R.J. Weil, A.H. Hamrahian, Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 95, 4555–4559 (2010)PubMedCrossRef R.K. Zerikly, L. Amiri, C. Faiman, M. Gupta, R.J. Singh, B. Nutter, L. Kennedy, B. Hatipoglu, R.J. Weil, A.H. Hamrahian, Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 95, 4555–4559 (2010)PubMedCrossRef
9.
Zurück zum Zitat W.W. Luthold, J.A. Marcondes, B.L. Wajchenberg, Salivary cortisol for the evaluation of Cushing’s syndrome. Clin. Chim. Acta. 151, 33–39 (1985)PubMedCrossRef W.W. Luthold, J.A. Marcondes, B.L. Wajchenberg, Salivary cortisol for the evaluation of Cushing’s syndrome. Clin. Chim. Acta. 151, 33–39 (1985)PubMedCrossRef
10.
Zurück zum Zitat M.H. Laudat, S. Cerdas, C. Fournier, D. Guiban, B. Guilhaume, J.P. Luton, Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J. Clin. Endocrinol. Metab. 66, 343–348 (1988)PubMedCrossRef M.H. Laudat, S. Cerdas, C. Fournier, D. Guiban, B. Guilhaume, J.P. Luton, Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J. Clin. Endocrinol. Metab. 66, 343–348 (1988)PubMedCrossRef
11.
Zurück zum Zitat H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)PubMedCrossRef H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)PubMedCrossRef
12.
Zurück zum Zitat M. Castro, P.C. Elias, A.R. Quidute, F.P. Halah, A.C. Moreira, Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J. Clin. Endocrinol. Metab. 84, 878–882 (1999)PubMedCrossRef M. Castro, P.C. Elias, A.R. Quidute, F.P. Halah, A.C. Moreira, Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J. Clin. Endocrinol. Metab. 84, 878–882 (1999)PubMedCrossRef
13.
Zurück zum Zitat D.A. Papanicolaou, N. Mullen, I. Kyrou, L.K. Nieman, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 87, 4515–4521 (2002)PubMedCrossRef D.A. Papanicolaou, N. Mullen, I. Kyrou, L.K. Nieman, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 87, 4515–4521 (2002)PubMedCrossRef
14.
Zurück zum Zitat P. Putignano, P. Toja, A. Dubini, F. Pecori Giraldi, S.M. Corsello, F. Cavagnini, Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 88, 4153–4157 (2003)PubMedCrossRef P. Putignano, P. Toja, A. Dubini, F. Pecori Giraldi, S.M. Corsello, F. Cavagnini, Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 88, 4153–4157 (2003)PubMedCrossRef
15.
Zurück zum Zitat M. Yaneva, H. Mosnier-Pudar, M.A. Dugue, S. Grabar, Y. Fulla, X. Bertagna, Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J. Clin. Endocrinol. Metab. 89, 3345–3351 (2004)PubMedCrossRef M. Yaneva, H. Mosnier-Pudar, M.A. Dugue, S. Grabar, Y. Fulla, X. Bertagna, Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J. Clin. Endocrinol. Metab. 89, 3345–3351 (2004)PubMedCrossRef
16.
Zurück zum Zitat M. Trilck, J. Flitsch, D.K. Ludecke, R. Jung, S. Petersenn, Salivary cortisol measurement–a reliable method for the diagnosis of Cushing’s syndrome. Exp. Clin. Endocrinol. Diabetes 113, 225–230 (2005)PubMedCrossRef M. Trilck, J. Flitsch, D.K. Ludecke, R. Jung, S. Petersenn, Salivary cortisol measurement–a reliable method for the diagnosis of Cushing’s syndrome. Exp. Clin. Endocrinol. Diabetes 113, 225–230 (2005)PubMedCrossRef
17.
Zurück zum Zitat S. Sakihara, K. Kageyama, Y. Oki, M. Doi, Y. Iwasaki, S. Takayasu, T. Moriyama, K. Terui, T. Nigawara, Y. Hirata, K. Hashimoto, T. Suda, Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr. J. 57, 331–337 (2010)PubMedCrossRef S. Sakihara, K. Kageyama, Y. Oki, M. Doi, Y. Iwasaki, S. Takayasu, T. Moriyama, K. Terui, T. Nigawara, Y. Hirata, K. Hashimoto, T. Suda, Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr. J. 57, 331–337 (2010)PubMedCrossRef
18.
Zurück zum Zitat G. Beko, I. Varga, E. Glaz, M. Sereg, K. Feldman, M. Toth, K. Racz, A. Patocs, Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin. Chim. Acta. 411, 364–367 (2010)PubMedCrossRef G. Beko, I. Varga, E. Glaz, M. Sereg, K. Feldman, M. Toth, K. Racz, A. Patocs, Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin. Chim. Acta. 411, 364–367 (2010)PubMedCrossRef
19.
Zurück zum Zitat C. Carrozza, S.M. Corsello, R.M. Paragliola, F. Ingraudo, S. Palumbo, P. Locantore, A. Sferrazza, A. Pontecorvi, C. Zuppi, Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann. Clin. Biochem. 47, 228–232 (2010)PubMedCrossRef C. Carrozza, S.M. Corsello, R.M. Paragliola, F. Ingraudo, S. Palumbo, P. Locantore, A. Sferrazza, A. Pontecorvi, C. Zuppi, Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann. Clin. Biochem. 47, 228–232 (2010)PubMedCrossRef
20.
Zurück zum Zitat F.P. Girardi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first line test for the diagnosis of Cushing’s Syndrome: assessment in a large serie. JCEM 92, 4123–4129 (2007) F.P. Girardi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first line test for the diagnosis of Cushing’s Syndrome: assessment in a large serie. JCEM 92, 4123–4129 (2007)
21.
Zurück zum Zitat B. Romer, S. Lewicka, D. Kopf, F. Lederbogen, B. Hamann, M. Gilles, C. Schilling, V. Onken, P. Frankhauser, M. Deuschle, Cortisol metabolism in depressed patients and healthy controls. Neuroendocrinology 90, 301–306 (2009)PubMedCrossRef B. Romer, S. Lewicka, D. Kopf, F. Lederbogen, B. Hamann, M. Gilles, C. Schilling, V. Onken, P. Frankhauser, M. Deuschle, Cortisol metabolism in depressed patients and healthy controls. Neuroendocrinology 90, 301–306 (2009)PubMedCrossRef
22.
Zurück zum Zitat H. Liu, D.M. Bravata, J. Cabaccan, H. Raff, E. Ryzen, Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin. Endocrinol. (Oxf) 63, 642–649 (2005)CrossRef H. Liu, D.M. Bravata, J. Cabaccan, H. Raff, E. Ryzen, Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin. Endocrinol. (Oxf) 63, 642–649 (2005)CrossRef
Metadaten
Titel
Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system
verfasst von
C. A. Carrasco
M. García
M. Goycoolea
J. Cerda
J. Bertherat
O. Padilla
D. Meza
N. Wohllk
T. Quiroga
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9597-z

Weitere Artikel der Ausgabe 3/2012

Endocrine 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.